Skip to the page

Data / Form D filings / Digital Therapeutics, Inc.

Digital Therapeutics, Inc.: Form D filings

Digital Therapeutics, Inc., a technology company in New York, NY, filed 4 Form D notices with the SEC between 2020 and 2024. The latest, on April 11, 2024, reports $50.5 million sold of a $50.5 million offering to 10 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1632 1st Ave, #20163, New York, NY, 10028
Phone
(877) 349-7755
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1805173

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 11, 2024New notice$50,499,903$50,499,90310Dec 21, 2023sec.gov
Aug 11, 2022New notice$15,299,979$11,499,981$3,799,9982Jul 27, 2022sec.gov
Jul 29, 2021New notice$49,499,929$49,499,9296Jul 14, 2021sec.gov
Mar 24, 2020New notice$13,709,995$12,139,185$1,570,81031Jan 30, 2020sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Yusuf SherwaniExecutive Officer, Director
Gabriel MecklenburgDirector
Will GibbsDirector
Maria MarasDirector
Sarim SiddiquiExecutive Officer, Director
Ben BlumeDirector
Maroof AhmedExecutive Officer, Director

Other technology companies in New York that filed recently

Every Form D from the week of Apr 8, 2024 · All recent filings in New York · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Digital Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.